228
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Bleeding Complications in Uremic Patients After Ultrasound-Guided Central Venous Catheter Placement

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 21-28 | Received 28 Jul 2022, Accepted 09 Dec 2022, Published online: 12 Jan 2023

References

  • Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ. Evidence-based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol. 2007;3:138–153. doi:10.1038/ncpneph0421
  • Galbusera M, Remuzzi G, Boccardo P. Treatment of bleeding in dialysis patients. Semin Dial. 2009;22:279–286. doi:10.1111/j.1525-139X.2008.00556.x
  • Steiner RW, Coggins C, Carvalho AC. Bleeding time in uremia: a useful test to assess clinical bleeding. Am J Hematol. 1979;7:107. doi:10.1002/ajh.2830070203
  • Eknoyan G, Wacksman SJ, Glueck HI, Will JJ. Platelet function in renal failure. N Engl J Med. 1969;280:677. doi:10.1056/NEJM196903272801301
  • Zachee P, Vermylen J, Boogaerts MA. Hematologic aspects of end-stage renal failure. Ann Hematol. 1994;69:33–40. doi:10.1007/BF01757345
  • Thekkedath UR, Chirananthavat T, Leypoldt JK, Cheung AK, Mohammad SF. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa. Am J Hematol. 2006;81:915–926. doi:10.1002/ajh.20720
  • Escolar G, Cases A, Bastida E, et al. Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa. Blood. 1990;76:1336. doi:10.1182/blood.V76.7.1336.1336
  • Benigni A, Boccardo P, Galbusera M, et al. Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia. Am J Kidney Dis. 1993;22:668. doi:10.1016/S0272-6386(12)80429-X
  • Mannucci PM, Tripodi A. Hemostatic defects in liver and renal dysfunction. Hematol Educ Progr Am Soc Hematol Soc Hematol Progr. 2012;2012:168–173. doi:10.1182/asheducation.V2012.1.168.3798232
  • Lin B-S, Huang T-P, Tang G-J, Der-Cherng Tarng C-WK, Kong C-W. Ultrasound-guided cannulation of the internal jugular vein for dialysis vascular access in uremic patients. Nephron. 1998;78(4):423–428. doi:10.1159/000044971
  • Tomizawa M, Shinozaki F, Hasegawa R, et al. Laboratory test variables useful for distinguishing upper from lower gastrointestinal bleeding. World J Gastroenterol. 2015;21(20):6246–6251. doi:10.3748/wjg.v21.i20.6246
  • Zia Ziabari SM, Rimaz S, Shafaghi A, et al. Blood urea nitrogen to creatinine ratio in differentiation of upper and lower gastrointestinal bleedings; a diagnostic accuracy study. Arch Acad Emerg Med. 2019;7(1):e30.
  • Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205–213. doi:10.7326/M14-1589
  • Van de Weerdt EK, Biemond BJ, Baake B, et al. Central venous catheter placement in coagulopathic patients: risk factors and incidence of bleeding complications. Transfusion. 2017;57(10):2512–2525. doi:10.1111/trf.14248
  • Ray CE, Shenoy SS. Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. Radiology. 1997;204(1):97–99. doi:10.1148/radiology.204.1.9205228
  • Agarwal SK, Dash SC, Dash SC, Dash SC. A prospective randomized study to compare ultrasound-guided with nonultrasound-guided double lumen internal jugular catheter insertion as a temporary hemodialysis access. Ren Fail. 2005;27(5):561–564. doi:10.1080/08860220500199084
  • Aydin Z, Gursu M, Uzun S, et al. Placement of hemodialysis catheters with a technical, functional, and anatomical viewpoint. Int J Nephrol. 2012;2012:5. doi:10.1155/2012/302826
  • Álvarez F. Accesos venosos centrales guiados por ultrasonido: ¿existe evidencia suficiente para justificar su uso de rutina? Rev Médica Clínica Las Condes. 2011;22(3):361–368. doi:10.1016/S0716-8640(11)70436-9
  • Jamale TE, Hase NK, Kulkarni M, et al. Earlier-start versus usual-start dialysis in patients with community-acquired acute kidney injury: a randomized controlled trial. Am J Kidney Dis. 2013;62:1116–1121. doi:10.1053/j.ajkd.2013.06.012
  • Bream PR. Update on insertion and complications of central venous catheters for hemodialysis. Semin Intervent Radiol. 2016;33(1):31–38. doi:10.1055/s-0036-1572547
  • Clark E, Kappel J, MacRae J, et al.; Canadian Society of Nephrology Vascular Access Work Group. Practical aspects of nontunneled and tunneled hemodialysis catheters. Can J Kidney Health Dis. 2016;3:2054358116669128. doi:10.1177/2054358116669128
  • Walser EM. Venous access ports: indications, implantation technique, follow-up, and complications. Cardiovasc Intervent Radiol. 2012;35(4):751–764. doi:10.1007/s00270-011-0271-2
  • Silva FS. Neck haematoma and airway obstruction in a patient with goitre: complication of internal jugular vein cannulation. Acta Anaesthesiol Scand. 2003;47(5):626–629. doi:10.1034/j.1399-6576.2003.00106.x
  • Sasvary F, Somlo P, Nwanosike N. Complications of central venous catheterization in hemodialysis patients. Bratisl Lek Listy. 2005;106(1):26–29.
  • Royo P, García-Testal A, Soldevila A, Panadero J, Cruz JM. Tunneled catheters. Complications during insertion. Nefrología. 2008;28(5):543–548.
  • Vats HS. Complications of catheters: tunneled and non tunneled. Adv Chronic Kidney Dis. 2012;19:188–194. doi:10.1053/j.ackd.2012.04.004
  • Napalkov P, Felici DM, Chu LK, et al. Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis. BMC Cardiovasc Disord. 2013;13:86. doi:10.1186/1471-2261-13-86
  • Weigand K, Encke J, Meyer FJ, et al. Low levels of prothrombin time (INR) and platelets do not increase the risk of significant bleeding when placing central venous catheters. Med Klin. 2009;104(5):331–335. doi:10.1007/s00063-009-1070-2
  • Hughes OU, Stella A, Samuel E. Complications of Internal jugular catheters in haemodialysis patients at a kidney care center in Nigeria. J Clin Nephrol. 2019;3:121–125. doi:10.29328/journal.jcn.1001037
  • Rabolink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int. 1994;46:287–296. doi:10.1038/ki.1994.274
  • Mannucci PM, Remuzzi G, Pusineri F, et al. Deamino-8-d-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med. 1983;308:8–12. doi:10.1056/NEJM198301063080102
  • Remuzzi G, Cavenaghi AE, Mecca G, Donati MB, De Gaetano G. Prostacyclin-like activity and bleeding in renal failure. Lancet. 1977;2:1195–1197. doi:10.1016/S0140-6736(77)90437-8
  • Remuzzi G, Pusineri F. Coagulation defects in uremia. Kidney Int. 1988;24:S13–17.
  • Noris M, Benigni A, Boccardo P, et al. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int. 1993;44:445–450. doi:10.1038/ki.1993.264
  • Eknoyan G, Brown CH. Biochemical abnormalities of platelets in renal failure. Evidence for decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase. Am J Nephrol. 1981;1:17–23. doi:10.1159/000166482
  • Benigni A, Boccardo P, Galbusera M, et al. Reversible activation defect of the platelet glycoprotein IIb—IIIa complex in patients with uremia. Am J Kidney Dis. 1993;22:668–676.
  • Napolitano M, Malato A, Raffaele F, et al. Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia. Blood Transfus. 2013;2013:1–5.
  • Haas B, Chittams JL, Trerotola SO. Large-bore tunneled central venous catheter insertion in patients with coagulopathy. J Vasc Interv Radiol. 2010;21:212–217. doi:10.1016/j.jvir.2009.10.032
  • Rabindranath KS, Kumar E, Shail R, Vaux EC. Ultrasound use for the placement of haemodialysis catheters. Cochrane Database Syst Rev. 2011;11:CD005279.
  • Hind D, Calvert N, McWilliams R, et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ. 2003;327:1–7. doi:10.1136/bmj.327.7411.361
  • Randolph AG, Cook DJ, Gonzales CA, Pribble CG. Ultrasound guidance for placement of central venous catheters. Crit Care Med. 1996;24(12):2053–2058. doi:10.1097/00003246-199612000-00020
  • Fragou M, Gravvanis A, Dimitriou V, et al. Real-time ultrasound-guided subclavian vein cannulation versus the landmark method in critical care patients: a prospective randomized study. Crit Care Med. 2011;39(7):1607–1612. doi:10.1097/CCM.0b013e318218a1ae
  • Wu SY, Ling Q, Cao LH, et al. Real-time two-dimensional ultrasound guidance for central venous cannulation: a meta-analysis. Anesthesiology. 2013;118(2):361–375. doi:10.1097/ALN.0b013e31827bd172
  • Brass P, Hellmich M, Kolodziej L, et al. Ultrasound guidance versus anatomical landmarks for subclavian or femoral vein catheterization. Cochrane Database Syst Rev. 2015;1:CD011447. doi:10.1002/14651858.CD011447
  • Rockholt MM, Thorarinsdottir HR, Lazarevic V, Rundgren M, Kander T. Central venous catheter-related complications in hematologic patients: an observational study. Acta Anaesthesiol Scand. 2022;66:473–482. doi:10.1111/aas.14020
  • Tercan F, Ozkan U, Oguzkurt L. US-guided placement of central vein catheters in patients with disorders of hemostasis. Eur J Radiol. 2008;65:253–256. doi:10.1016/j.ejrad.2007.04.002
  • Parienti JJ, Mongardon N, Mégarbane B, et al. Intravascular complications of central venous catheterization by insertion site. N Engl J Med. 2015;373(13):1220–1229. doi:10.1056/NEJMoa1500964
  • Jodi B, Dzik WH; Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence‐based review. Transfusion. 2005;45:1413–1425. doi:10.1111/j.1537-2995.2005.00546.x
  • Schiffer CA, Bohlke K, Delaney M, et al. Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2018;36(3):283–299. doi:10.1200/JCO.2017.76.1734
  • Patel IJ, Davidson JC, Nikolic B, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23(6):727–736. doi:10.1016/j.jvir.2012.02.012
  • National Institute for Health and Care Excellence (UK). Blood Transfusion. National Institute for Health and Care Excellence (UK); 2015.
  • Rath CE, Mailliard JA, Schreiner GE. Bleeding tendency in uremia. N Engl J Med. 1957;257(17):808–811. doi:10.1056/NEJM195710242571704
  • Ferguson JH, Lewis JH, Zucker MB. Bleeding tendency in uremia. Blood. 1956;11(12):1073–1076. doi:10.1182/blood.V11.12.1073.1073
  • Molino D, De Lucia D, Gaspare De Santo N. Coagulation disorders in uremia. Semin Nephrol. 2006;26(1):46–51. doi:10.1016/j.semnephrol.2005.06.011
  • Weigert AL, Schafer AI. Uremic bleeding: pathogenesis and therapy. Am J Med Sci. 1998;316(2):94–104. doi:10.1097/00000441-199808000-00005
  • Zeck J, Schallheim J, Lew SQ, De Palma L. Whole blood platelet aggregation and release reaction testing in uremic patients. Biomed Res Int. 2013;2013:6. doi:10.1155/2013/486290